Weight loss-induced changes in adipose tissue proteins associated with fatty acid and glucose metabolism correlate with adaptations in energy expenditure
Camps SG., Verhoef SP., Roumans N., Bouwman FG., Mariman EC., Westerterp KR.
Clinical Trial with a reported sample of 18, published in Nutr Metab (Lond) (2015) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Nutr Metab (Lond) (2015)
- Reported sample size
- 18
- Source database
- Europe PMC
- PMID
- 26500687
- PMCID
- PMC4619469
- DOI
- 10.1186/s12986-015-0034-1
- NCT
- NCT01015508
- Citations
- 7
Abstract (original English)
Background Energy restriction causes adaptations in energy expenditure (total-,TEE; resting-,REE; activity induced-,AEE). Objective To determine if changes in the levels of proteins involved in adipocyte glucose and fatty acid metabolism as indicators for energy deficiency are related to adaptations in energy expenditure during weight loss. Methods Forty-eight healthy subjects (18 men, 30 women), mean ± SD age 42 ± 8 y and BMI 31.4 ± 2.8 kg/m(2), followed a very low energy diet for 8 wk. Protein levels of fatty acid binding protein 4 (FABP4), fructose-bisphosphate aldolase C (AldoC) and short chain 3-hydroxyacyl-CoA dehydrogenase (HADHsc) (adipose tissue biopsy, western blot), TEE (doubly labeled water), REE (ventilated hood), and AEE were assessed before and after the 8-wk diet. Results There was a positive correlation between the decrease in AldoC and the decrease in TEE (R = 0.438, P Conclusion The decrease in AldoC correlated with the decrease in AEE, which may be explained by a decreased glycolytic flux. Additionally, the change in HADHsc, a crucial enzyme for a step in beta-oxidation, correlated with the adaptation in REE. Trial registration Clinical trial registration number NCT01015508 at clinicaltrials.gov.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.